Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858845 · ClinicalTrials.gov registry record · Phase 4
Using Clonidine to Improve Leg Weakness in People With Heart Failure
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00858845 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 11 participants.
The verdict
NCT00858845, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
People with heart failure often have weakness in their leg muscles. This study will determine whether the leg weakness is due to very high adrenaline levels and whether the medication clonidine can improve leg weakness.
Interventions
- DRUG Clonidine Patch
- OTHER Matching Placebo Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00858845
The ClinicalTrials.gov registry entry for NCT00858845 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clonidine Patch is the first listed.
NCT00858845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00858845 about?
NCT00858845 is a clinical study titled "Using Clonidine to Improve Leg Weakness in People With Heart Failure". People with heart failure often have weakness in their leg muscles. This study will determine whether the leg weakness is due to very high adrenaline levels and whether the medication clonidine can improve leg weakness.
What is the current status of trial NCT00858845?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-05. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00858845?
The interventions under investigation include: Clonidine Patch (DRUG), Matching Placebo Patch (OTHER).
Who is sponsoring clinical trial NCT00858845?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.